As of Oct 16
| -0.035 / -0.81%|
The 1 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +62.60% increase from the last price of 4.31.
The current consensus among 2 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since October, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.